Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery

Younglan Kwak, Jong Chan Kim, Yong Seon Choi, Kyung Jong Yoo, Young Song, Jae Kwang Shim

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Objectives The purpose of this study was to evaluate the association of the percentage of platelet inhibitory response to clopidogrel as assessed by modified thromboelastography with bleeding and transfusion requirement after off-pump coronary artery bypass graft (OPCABG) surgery. Background Interindividual variability of clopidogrel responsiveness may influence bleeding and transfusion requirement. Methods One hundred patients who received clopidogrel within 5 days of OPCABG were prospectively enrolled. The primary end point was to compare post-operative bleeding and transfusion requirement in relation to the tertile distribution of the percentage of platelet inhibitory response to clopidogrel. Results Blood loss in the patients in the third tertile was 914 ± 264 ml compared with 623 ± 249 ml in those in the first and 683 ± 254 ml in those in the second tertiles (p = 0.001). Significantly more patients in the third tertile were transfused, and the number of units transfused was also larger. On multivariate analysis, the third tertile was associated with an 11-fold increased risk of transfusion (95% confidence interval: 2.77 to 47.30, p = 0.001). The optimal cutoff value for the transfusion requirement measured by receiver-operator characteristic curve analysis was 70% platelet inhibitory response to clopidogrel (area under the curve: 0.771; 95% confidence interval: 0.674 to 0.868; p < 0.001). Conclusions A high percentage of platelet inhibitory response to clopidogrel, regardless of the proximity of clopidogrel exposure, predicts increased blood loss and transfusion requirement after OPCABG with a cutoff value of 70% for increased risk of transfusion. These findings might implicate a potential role of modified thromboelastography in deciding the timing of OPCABG in patients who need continued clopidogrel therapy.

Original languageEnglish
Pages (from-to)1994-2002
Number of pages9
JournalJournal of the American College of Cardiology
Volume56
Issue number24
DOIs
Publication statusPublished - 2010 Dec 7

Fingerprint

clopidogrel
Off-Pump Coronary Artery Bypass
Coronary Artery Bypass
Blood Transfusion
Transplants
Blood Platelets
Thrombelastography
Hemorrhage
Confidence Intervals

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

@article{35d100a5b2a44a12a7a0c899b7770cbd,
title = "Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery",
abstract = "Objectives The purpose of this study was to evaluate the association of the percentage of platelet inhibitory response to clopidogrel as assessed by modified thromboelastography with bleeding and transfusion requirement after off-pump coronary artery bypass graft (OPCABG) surgery. Background Interindividual variability of clopidogrel responsiveness may influence bleeding and transfusion requirement. Methods One hundred patients who received clopidogrel within 5 days of OPCABG were prospectively enrolled. The primary end point was to compare post-operative bleeding and transfusion requirement in relation to the tertile distribution of the percentage of platelet inhibitory response to clopidogrel. Results Blood loss in the patients in the third tertile was 914 ± 264 ml compared with 623 ± 249 ml in those in the first and 683 ± 254 ml in those in the second tertiles (p = 0.001). Significantly more patients in the third tertile were transfused, and the number of units transfused was also larger. On multivariate analysis, the third tertile was associated with an 11-fold increased risk of transfusion (95{\%} confidence interval: 2.77 to 47.30, p = 0.001). The optimal cutoff value for the transfusion requirement measured by receiver-operator characteristic curve analysis was 70{\%} platelet inhibitory response to clopidogrel (area under the curve: 0.771; 95{\%} confidence interval: 0.674 to 0.868; p < 0.001). Conclusions A high percentage of platelet inhibitory response to clopidogrel, regardless of the proximity of clopidogrel exposure, predicts increased blood loss and transfusion requirement after OPCABG with a cutoff value of 70{\%} for increased risk of transfusion. These findings might implicate a potential role of modified thromboelastography in deciding the timing of OPCABG in patients who need continued clopidogrel therapy.",
author = "Younglan Kwak and Kim, {Jong Chan} and Choi, {Yong Seon} and Yoo, {Kyung Jong} and Young Song and Shim, {Jae Kwang}",
year = "2010",
month = "12",
day = "7",
doi = "10.1016/j.jacc.2010.03.108",
language = "English",
volume = "56",
pages = "1994--2002",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "24",

}

Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery. / Kwak, Younglan; Kim, Jong Chan; Choi, Yong Seon; Yoo, Kyung Jong; Song, Young; Shim, Jae Kwang.

In: Journal of the American College of Cardiology, Vol. 56, No. 24, 07.12.2010, p. 1994-2002.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery

AU - Kwak, Younglan

AU - Kim, Jong Chan

AU - Choi, Yong Seon

AU - Yoo, Kyung Jong

AU - Song, Young

AU - Shim, Jae Kwang

PY - 2010/12/7

Y1 - 2010/12/7

N2 - Objectives The purpose of this study was to evaluate the association of the percentage of platelet inhibitory response to clopidogrel as assessed by modified thromboelastography with bleeding and transfusion requirement after off-pump coronary artery bypass graft (OPCABG) surgery. Background Interindividual variability of clopidogrel responsiveness may influence bleeding and transfusion requirement. Methods One hundred patients who received clopidogrel within 5 days of OPCABG were prospectively enrolled. The primary end point was to compare post-operative bleeding and transfusion requirement in relation to the tertile distribution of the percentage of platelet inhibitory response to clopidogrel. Results Blood loss in the patients in the third tertile was 914 ± 264 ml compared with 623 ± 249 ml in those in the first and 683 ± 254 ml in those in the second tertiles (p = 0.001). Significantly more patients in the third tertile were transfused, and the number of units transfused was also larger. On multivariate analysis, the third tertile was associated with an 11-fold increased risk of transfusion (95% confidence interval: 2.77 to 47.30, p = 0.001). The optimal cutoff value for the transfusion requirement measured by receiver-operator characteristic curve analysis was 70% platelet inhibitory response to clopidogrel (area under the curve: 0.771; 95% confidence interval: 0.674 to 0.868; p < 0.001). Conclusions A high percentage of platelet inhibitory response to clopidogrel, regardless of the proximity of clopidogrel exposure, predicts increased blood loss and transfusion requirement after OPCABG with a cutoff value of 70% for increased risk of transfusion. These findings might implicate a potential role of modified thromboelastography in deciding the timing of OPCABG in patients who need continued clopidogrel therapy.

AB - Objectives The purpose of this study was to evaluate the association of the percentage of platelet inhibitory response to clopidogrel as assessed by modified thromboelastography with bleeding and transfusion requirement after off-pump coronary artery bypass graft (OPCABG) surgery. Background Interindividual variability of clopidogrel responsiveness may influence bleeding and transfusion requirement. Methods One hundred patients who received clopidogrel within 5 days of OPCABG were prospectively enrolled. The primary end point was to compare post-operative bleeding and transfusion requirement in relation to the tertile distribution of the percentage of platelet inhibitory response to clopidogrel. Results Blood loss in the patients in the third tertile was 914 ± 264 ml compared with 623 ± 249 ml in those in the first and 683 ± 254 ml in those in the second tertiles (p = 0.001). Significantly more patients in the third tertile were transfused, and the number of units transfused was also larger. On multivariate analysis, the third tertile was associated with an 11-fold increased risk of transfusion (95% confidence interval: 2.77 to 47.30, p = 0.001). The optimal cutoff value for the transfusion requirement measured by receiver-operator characteristic curve analysis was 70% platelet inhibitory response to clopidogrel (area under the curve: 0.771; 95% confidence interval: 0.674 to 0.868; p < 0.001). Conclusions A high percentage of platelet inhibitory response to clopidogrel, regardless of the proximity of clopidogrel exposure, predicts increased blood loss and transfusion requirement after OPCABG with a cutoff value of 70% for increased risk of transfusion. These findings might implicate a potential role of modified thromboelastography in deciding the timing of OPCABG in patients who need continued clopidogrel therapy.

UR - http://www.scopus.com/inward/record.url?scp=78649703433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649703433&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2010.03.108

DO - 10.1016/j.jacc.2010.03.108

M3 - Article

VL - 56

SP - 1994

EP - 2002

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 24

ER -